ストックスクリーナーアプリを入手
2.10
0.96%
0.02
前日終値:
$2.08
開ける：
$2.11
24時間の取引高:
706.99K
Relative Volume:
1.32
時価総額：
$78.50M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-9.87%
1か月 パフォーマンス:
+45.83%
6か月 パフォーマンス:
-24.19%
1年 パフォーマンス:
-60.00%
1日の値動き範囲:
$2.07
$2.25
1週間の範囲:
$2.04
$2.40
52週間の値動き範囲:
$1.23
$5.38
Metagenomi Inc Stock (MGX) Company Profile
MGX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MGX
Metagenomi Inc
|
2.10 | 87.10M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.55 | 123.00B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.93 | 59.66B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.81 | 41.84B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
577.92 | 33.98B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
279.16 | 27.67B | 3.81B | -644.79M | -669.77M | -6.24 |
Metagenomi Inc Stock (MGX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-05-07 | 開始されました | H.C. Wainwright | Buy |
| 2024-05-02 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-03-05 | 開始されました | BMO Capital Markets | Outperform |
| 2024-03-05 | 開始されました | Chardan Capital Markets | Buy |
| 2024-03-05 | 開始されました | JP Morgan | Overweight |
| 2024-03-05 | 開始されました | Jefferies | Buy |
| 2024-03-05 | 開始されました | TD Cowen | Outperform |
| 2024-03-05 | 開始されました | Wells Fargo | Overweight |
すべてを表示
Metagenomi Inc (MGX) 最新ニュース
why metagenomi inc. stock attracts strong analyst attentionFree Stock Trading Signals - Newser
Why Metagenomi Inc. stock attracts strong analyst attentionTargeted 200 Percent Gain - Newser
How Metagenomi Inc. stock performs during market volatilityDouble Your Capital Alerts - Newser
What makes Metagenomi Inc. stock price move sharplyDaily Price Surge List - Newser
Metagenomi Showcases Advanced AI-Enhanced Gene Editing for Neurological Disorders at ASGCT Meeting - Insider Monkey
12 Best Young Stocks To Buy and Hold For 5 Years - Insider Monkey
Metagenomi, Inc. shares fall 1.29% in after-hours trading following positive market report and collaboration updates. - AInvest
Metagenomi, Inc.(NasdaqGS: MGX) dropped from Russell 2500 Index - MarketScreener
Critical Survey: Guardian Pharmacy Services (NYSE:GRDN) & Metagenomi (NASDAQ:MGX) - Defense World
Sam Altman Says He 'Didn't Think' Elon Musk Would Abuse Government Power, Tesla CEO Hits Back With 'Scam Altman' JibeOracle (NYSE:ORCL), Metagenomi (NASDAQ:MGX) - Benzinga
Eli Lilly's $1.3 Billion Verve Deal Signals Confidence In Gene Editing Space: Analyst - Benzinga
Metagenomi Requests to Dismiss Class Action Filed by Investors - TradingView
Metagenomi, Inc. (NASDAQ:MGX) Shares Sold by Millennium Management LLC - Defense World
Two Sigma Investments LP Sells 59,135 Shares of Metagenomi, Inc. (NASDAQ:MGX) - Defense World
Metagenomi CEO Thomas Brian sells shares worth $18,873 By Investing.com - Investing.com India
Metagenomi CEO Thomas Brian sells shares worth $18,873 - Investing.com
Metagenomi Executives Sell Shares to Cover Tax Obligations - TradingView
Metagenomi Director Irish Jian Sells Shares to Cover Tax Obligations - TradingView
Jane Street Group LLC Invests $107,000 in Metagenomi, Inc. (NASDAQ:MGX) - Defense World
Nuveen Asset Management LLC Buys Shares of 63,248 Metagenomi, Inc. (NASDAQ:MGX) - Defense World
Metagenomi Being Investigated on Behalf of Metagenomi, Inc. Investors. Contact Levi & Korsinsky For Details - ACCESS Newswire
Adverum Biotechnologies (NASDAQ:ADVM) versus Metagenomi (NASDAQ:MGX) Head-To-Head Analysis - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Purchases 11,730 Shares of Metagenomi, Inc. (NASDAQ:MGX) - Defense World
Metagenomi, Inc. (NASDAQ:MGX) Short Interest Down 18.9% in May - Defense World
Citadel Advisors LLC Decreases Position in Metagenomi, Inc. (NASDAQ:MGX) - Defense World
Northern Trust Corp Raises Position in Metagenomi, Inc. (NASDAQ:MGX) - Defense World
What is HC Wainwright’s Forecast for Metagenomi Q2 Earnings? - Defense World
Equities Analysts Issue Forecasts for Metagenomi Q1 Earnings - Defense World
Metagenomi Inc (NASDAQ: MGX): Finding Hidden Gems Among Volatility - Stocksregister
MGX ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Metagenomi, Inc. investment - ACCESS Newswire
Price T Rowe Associates Inc. MD Buys New Holdings in Metagenomi, Inc. (NASDAQ:MGX) - Defense World
Chardan Capital Has Lowered Expectations for Metagenomi (NASDAQ:MGX) Stock Price - Defense World
Metagenomi, Inc. (NASDAQ:MGX) Analysts Are Cutting Their Estimates: Here's What You Need To Know - Yahoo Finance
Voya Investment Management LLC Acquires Shares of 10,314 Metagenomi, Inc. (NASDAQ:MGX) - Defense World
Demystifying Metagenomi: Insights From 4 Analyst Reviews - Benzinga
Chardan Cuts Price Target on Metagenomi to $12 From $13, Keeps Buy Rating - marketscreener.com
Metagenomi, Inc. (NASDAQ:MGX) Shares Bought by Barclays PLC - Defense World
Metagenomi price target lowered to $16 from $20 at Wells Fargo - TipRanks
Metagenomi Presents Data Highlighting Advancements in Next-Generation Genome Editing ... - Bluefield Daily Telegraph
Metagenomi Presents Data Highlighting Advancements in Next-Generation Genome Editing Technologies at ASGCT Annual Meeting 2025 - Yahoo Finance
Metagenomi Presents Data Highlighting Advancements in - GlobeNewswire
Metagenomi (MGX) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
Metagenomi: Q1 Earnings Snapshot - San Francisco Chronicle
Metagenomi reports Q1 EPS (68c), consensus (51c) - TipRanks
Metagenomi Reports Positive NHP Study Results for Hemophilia A Program and Quarterly Financials - Nasdaq
Metagenomi Reports Business Updates and First Quarter 2025 Financial Results - The Manila Times
Metagenomi Q1 Earnings: Breakthrough Hemophilia Treatment Maintains 75% Effectiveness After 19 Months - Stock Titan
Metagenomi Inc (MGX) 財務データ
Metagenomi Inc (MGX) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
3.40%
2.49%
大文字化:
|
ボリューム (24 時間):